GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (CHIX:MITRAb) » Definitions » Net Margin %
中文

Mithra Pharmaceuticals (CHIX:MITRAB) Net Margin % : -717.40% (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Mithra Pharmaceuticals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Mithra Pharmaceuticals's Net Income for the six months ended in Jun. 2023 was €-50.47 Mil. Mithra Pharmaceuticals's Revenue for the six months ended in Jun. 2023 was €7.04 Mil. Therefore, Mithra Pharmaceuticals's net margin for the quarter that ended in Jun. 2023 was -717.40%.

The historical rank and industry rank for Mithra Pharmaceuticals's Net Margin % or its related term are showing as below:

CHIX:MITRAb' s Net Margin % Range Over the Past 10 Years
Min: -1019.78   Med: -68.53   Max: -8.64
Current: -125.8


CHIX:MITRAb's Net Margin % is ranked worse than
86.67% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.765 vs CHIX:MITRAb: -125.80

Mithra Pharmaceuticals Net Margin % Historical Data

The historical data trend for Mithra Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mithra Pharmaceuticals Net Margin % Chart

Mithra Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.36 -27.52 -1,019.78 -515.59 -88.99

Mithra Pharmaceuticals Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -452.10 -588.84 -275.13 -50.99 -717.40

Competitive Comparison of Mithra Pharmaceuticals's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mithra Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mithra Pharmaceuticals's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mithra Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Mithra Pharmaceuticals's Net Margin % falls into.



Mithra Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Mithra Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-59.62/66.997
=-88.99 %

Mithra Pharmaceuticals's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin=Net Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-50.469/7.035
=-717.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mithra Pharmaceuticals  (CHIX:MITRAb) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Mithra Pharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of Mithra Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mithra Pharmaceuticals (CHIX:MITRAB) Business Description

Traded in Other Exchanges
Address
Rue Saint-Georges 5, Liege, BEL, 4000
Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.

Mithra Pharmaceuticals (CHIX:MITRAB) Headlines

No Headlines